
OVUM HEALTH
OperatingOVUM HEALTH INC.
Healthcare · Sagle, ID · Founded 2023
Proven fertility treatment at home, covered by insurance
Financials
FY2022–FY2023 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inBlue bars are the pre-money valuation the company stated for a priced round.
Fundraising history
Team
6 people
Alice Crisci is a venture-backed entrepreneur in health technology, activist, author and cancer survivor. She’s co-authored multiple health care laws and spun out Ovum Health to improve the health of moms-to-be and their babies. Alice will be providing Form C sign-off as the Company's Principal Accounting Officer. Alice is employed as a contractor for Ovum.

Kirby Plessala, MD, is an ObGyn who has been in practice since 1994. As of January 2023, he now concentrates on fertility and hormone management for patients. He is also a medical device inventor and has a physical practice in Mobile, AL as well as being a co-founder of the telehealth company, Ovum Health. He is an award-winning OBGYN. Kirby is employed as a contractor for Ovum.

Latrice Allen is Ovum’s Chief Patient Advocate, with 30 years' experience helping women and couples create families. She helps patients navigate the complex choices facing them when they need medical assistance to form their family. With deep expertise in donor conception and third party reproduction, she educates patients on insurance options and how to advocate for themselves. She informs patients of research opportunities. Latrice is employed as a contractor for Ovum.

Lauren Haring has been a registered nurse for two decades and spent 16 years on the front lines caring for patients at a world-renowned fertility clinic. Lauren serves as SVP of Operations for Ovum Health, an on-demand fertility telehealth platform transforming women's health and reproductive care. She also has a personal connection to the fertility community as a former egg donor, #1in4, and has also frozen her eggs! Lauren shares openly about her experiences and as an active member of ASRM and RESOLVE, she is continuously bringing awareness and educating her local community about reproductive options. Lauren is employed as a contractor for Ovum.

Dr. Santiago Munne Blanco developed the first tests for Testing chromosome abnormalities in embryos. He founded six companies in reproductive medicine: Reprogenetics, Recombine, Phosphorus, MedAnswers, Overture Life and HoMu Health ventures. Currently he is the Scientific Director of Progenesis and President of HoMu. Santiago is employed as a contractor by Ovum Health.

"Rohini Kosoglu is a national policy expert and veteran of the White House, Congress, and presidential campaigns. She is a Policy Fellow at Stanford's Institute for Human-Centered AI and a Venture Partner at Fusion Fund. Recently, she served in the White House as Deputy Assistant to the President and Domestic Policy Advisor to the Vice President where Vice President Harris praised Rohini as a “a brilliant and trusted leader” who “brought vision, strategic judgement, and a depth of experience as our Administration has addressed some of the most urgent challenges facing our nation.” She was the first South Asian American woman in her White House role and as Chief of Staff in the United States Senate. She has over a decade of Senate experience, working with Senators Kamala Harris, Michael Bennet of Colorado, and Debbie Stabenow of Michigan, and was a key negotiator of the Affordable Care Act and the 21st Century Cures Act amongst other laws."
Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 0 of 2 annual reports (FY2024–FY2025)
Missing: 2024, 2025
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.